文章來源：華(hua)潤（集團）有限公司 發(fa)布時(shi)間：2009-08-26
華潤(run)集(ji)團旗(qi)下三九(jiu)醫藥股份有(you)限(xian)公(gong)司(si)發布2008年(nian)半年(nian)度報告(gao)，公(gong)司(si)實(shi)(shi)現(xian)營(ying)業收(shou)入19.10億元(yuan)(yuan)，同比增(zeng)長19.94％；營(ying)業利潤(run)2.77億元(yuan)(yuan)，同比增(zeng)長116.55％；歸屬(shu)于母公(gong)司(si)的(de)(de)凈(jing)利潤(run)為(wei)2.09億元(yuan)(yuan)，同比增(zeng)長122.95％；實(shi)(shi)現(xian)每股收(shou)益0.21元(yuan)(yuan)。公(gong)告(gao)還稱，經財(cai)務部門初步(bu)測算，預計今年(nian)前九(jiu)個月，實(shi)(shi)現(xian)的(de)(de)歸屬(shu)于母公(gong)司(si)所有(you)者的(de)(de)凈(jing)利潤(run)與上年(nian)同期相(xiang)比增(zeng)長100%-150%。
今年(nian)上(shang)半年(nian)，三(san)九(jiu)醫藥(yao)股份公(gong)司醫藥(yao)工業收入同(tong)(tong)比(bi)(bi)增(zeng)(zeng)(zeng)長(chang)23.72%，其中(zhong)OTC銷(xiao)(xiao)售(shou)(shou)額(e)同(tong)(tong)比(bi)(bi)增(zeng)(zeng)(zeng)長(chang)14%，中(zhong)藥(yao)處方藥(yao)銷(xiao)(xiao)售(shou)(shou)額(e)同(tong)(tong)比(bi)(bi)增(zeng)(zeng)(zeng)長(chang)50%，抗生(sheng)(sheng)素(su)及原料(liao)藥(yao)銷(xiao)(xiao)售(shou)(shou)額(e)同(tong)(tong)比(bi)(bi)增(zeng)(zeng)(zeng)長(chang)66%，延續了較快的增(zeng)(zeng)(zeng)長(chang)勢頭(tou)，免(mian)煎(jian)中(zhong)藥(yao)銷(xiao)(xiao)售(shou)(shou)額(e)同(tong)(tong)比(bi)(bi)增(zeng)(zeng)(zeng)長(chang)55%。產品方面，主(zhu)打產品感(gan)冒(mao)靈(ling)銷(xiao)(xiao)售(shou)(shou)同(tong)(tong)比(bi)(bi)增(zeng)(zeng)(zeng)長(chang)26%，達(da)到2.65億元(yuan)；皮(pi)(pi)炎(yan)平(ping)軟膏銷(xiao)(xiao)售(shou)(shou)達(da)到2.46億元(yuan)，同(tong)(tong)比(bi)(bi)增(zeng)(zeng)(zeng)長(chang)12.60%，參附及生(sheng)(sheng)脈銷(xiao)(xiao)售(shou)(shou)分別增(zeng)(zeng)(zeng)長(chang)52%及230%，三(san)九(jiu)皮(pi)(pi)炎(yan)平(ping)、三(san)九(jiu)胃泰保持(chi)平(ping)穩；新(xin)產品小兒(er)感(gan)冒(mao)靈(ling)、復(fu)方氨酚烷胺、無(wu)水頭(tou)孢唑林(lin)鈉等增(zeng)(zeng)(zeng)長(chang)快速。